A new method to calculate the beat-to-beat instability of QT duration in drug-induced long QT in anesthetized dogs (Q46527591)

22 December 2017

title

A new method to calculate the beat-to-beat instability of QT duration in drug-induced long QT in anesthetized dogs (English)

1 reference

22 December 2017

author name string

H van der Linde

1

1 reference

22 December 2017

A Van de Water

2

1 reference

22 December 2017

W Loots

3

1 reference

22 December 2017

B Van Deuren

4

1 reference

22 December 2017

H R Lu

5

1 reference

22 December 2017

K Van Ammel

6

1 reference

22 December 2017

M Peeters

7

1 reference

22 December 2017

D J Gallacher

8

1 reference

22 December 2017

publication date

1 July 2005

1 reference

22 December 2017

Journal of Pharmacological and Toxicological Methods

published in

1 reference

22 December 2017

volume

52

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

168-177

1 reference

22 December 2017

Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

The pharmacokinetics and pharmacodynamics of oral dofetilide after twice daily and three times daily dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Cellular mechanisms underlying the long QT syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Assessing predictors of drug-induced torsade de pointes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Temporal repolarization lability differences among genotyped patients with the long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Do existing measures of Poincaré plot geometry reflect nonlinear features of heart rate variability?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Poincaré plot interpretation using a physiological model of HRV based on a network of oscillators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Drug-induced torsades de pointes and implications for drug development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

The assessment of potential for QT interval prolongation with new pharmaceuticals: impact on drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Developing a strategy for the nonclinical assessment of proarrhythmic risk of pharmaceuticals due to prolonged ventricular repolarization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Blinded test in isolated female rabbit heart reliably identifies action potential duration prolongation and proarrhythmic drugs: importance of triangulation, reverse use dependence, and instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Application of the Poincaré plot to heart rate variability: a new measure of functional status in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

New preclinical guidelines on drug effects on ventricular repolarization: safety pharmacology comes of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Drug-induced long QT in isolated rabbit Purkinje fibers: importance of action potential duration, triangulation and early afterdepolarizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Functional assessment of heart rate variability: physiological basis and practical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

An improved method to correct the QT interval of the electrocardiogram for changes in heart rate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Some statistical methods useful in circulation research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Dofetilide: first of a new generation of class III agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Drug induced QT prolongation and torsades de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

Monophasic action potentials in the diagnosis of triggered arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.03.005

10.1016/J.VASCN.2005.03.005

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017